Literature DB >> 29356332

Feasibility and preliminary efficacy of a smartphone application intervention for subthreshold depression.

Kana Takahashi1, Koki Takada1, Kazuki Hirao1.   

Abstract

AIM: We developed a motion picture-reproducing smartphone application (app) designed to improve self-confidence in individuals with subthreshold depression (StD) and examined the feasibility and preliminary efficacy of an app intervention for individuals with StD.
METHODS: We conducted an open-label, single-arm pre-post study of 22 young adults with StD. Our intervention involved app usage for at least 70 min/wk for 5 weeks. The primary outcome measure was the adherence rate. Secondary outcome measures were safety and Center for Epidemiologic Studies Depression Scale (CES-D) scores.
RESULTS: No participants dropped out during the study. The adherence rate was 50%. The mean time of app use over 5 weeks was 124.23 ± 81.94 min/wk. No adverse events were reported. The CES-D scores were significantly improved at 5 weeks post-intervention.
CONCLUSIONS: Although this app intervention has the potential to reduce depressive symptoms, the app needs to be improved to increase adherence rates.
© 2018 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  application; eHealth; mHealth; smartphone; subthreshold depression

Mesh:

Year:  2018        PMID: 29356332     DOI: 10.1111/eip.12540

Source DB:  PubMed          Journal:  Early Interv Psychiatry        ISSN: 1751-7885            Impact factor:   2.732


  8 in total

1.  Positive-word stimuli via a smartphone application have no immediate-term effects on multi-directional reach ability in standing position: a randomized controlled trial.

Authors:  Kenta Azukizawa; Kodai Hirose; Yuta Morigami; Naoki Higashi; Hiroyuki Uchida; Kazuki Hirao
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

2.  Effects of Smartphone-Delivered Positive-Word Stimulation on Depressed Mood in People with Subthreshold Depression: Protocol for a Pilot Randomized Controlled Trial.

Authors:  Hitomi Ejiri; Hiroyuki Uchida; Kenji Tsuchiya; Kazuhiko Fujiwara; Senichiro Kikuchi; Kazuki Hirao
Journal:  Neuropsychiatr Dis Treat       Date:  2021-08-20       Impact factor: 2.570

3.  An iPad application-based intervention for improving post-stroke depression symptoms in a convalescent rehabilitation ward: A pilot randomized controlled clinical trial protocol.

Authors:  Hiroyuki Uchida; Yoshiya Hiragaki; Yuta Nishi; Shiori Nakahara; Junki Koumoto; Yusuke Onmyoji; Norimasa Fujimoto; Kazuho Kawakami; Masato Ishii; Kazuki Hirao
Journal:  Internet Interv       Date:  2020-08-27

4.  Smartphone-Based Interventions and Internalizing Disorders in Youth: Systematic Review and Meta-analysis.

Authors:  Adrian Buttazzoni; Keshbir Brar; Leia Minaker
Journal:  J Med Internet Res       Date:  2021-01-11       Impact factor: 5.428

Review 5.  Engagement with mobile health interventions for depression: A systematic review.

Authors:  Anthony Molloy; Page L Anderson
Journal:  Internet Interv       Date:  2021-09-11

Review 6.  Smartphone Apps for the Treatment of Mental Disorders: Systematic Review.

Authors:  Ignacio Miralles; Carlos Granell; Laura Díaz-Sanahuja; William Van Woensel; Juana Bretón-López; Adriana Mira; Diana Castilla; Sven Casteleyn
Journal:  JMIR Mhealth Uhealth       Date:  2020-04-02       Impact factor: 4.773

7.  Study protocol for a pilot randomized controlled trial on a smartphone application-based intervention for subthreshold depression: Study protocol clinical trial (SPIRIT Compliant).

Authors:  Yudai Kato; Kaito Kageyama; Takanori Mesaki; Hiroyuki Uchida; Yoshiyuki Sejima; Risako Marume; Kana Takahashi; Kazuki Hirao
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

Review 8.  Characteristics of Mobile Health Platforms for Depression and Anxiety: Content Analysis Through a Systematic Review of the Literature and Systematic Search of Two App Stores.

Authors:  Alexandria Remus; Dean Ho; Qiao Ying Leong; Shreya Sridhar; Agata Blasiak; Xavier Tadeo; GeckHong Yeo
Journal:  J Med Internet Res       Date:  2022-02-04       Impact factor: 5.428

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.